These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 3338115
1. Palmitoylcarnitine reverses 12-O-tetradecanoylphorbol-13-acetate-induced refractory state for the TPA-caused ornithine decarboxylase induction in mouse epidermis. Aizu E, Yamamoto S, Nakadate T, Kiyoto I, Kato R. Carcinogenesis; 1988 Feb; 9(2):309-13. PubMed ID: 3338115 [Abstract] [Full Text] [Related]
2. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and epidermal ornithine decarboxylase activity in mouse skin by palmitoylcarnitine. Nakadate T, Yamamoto S, Aizu E, Kato R. Cancer Res; 1986 Apr; 46(4 Pt 1):1589-93. PubMed ID: 3081251 [Abstract] [Full Text] [Related]
3. Tumor promoter-induced refractory state against ornithine decarboxylase induction by 12-O-tetradecanoylphorbol-13-acetate in mouse epidermis. Takigawa M, Simsiman RC, Boutwell RK. Cancer Res; 1986 Jan; 46(1):106-12. PubMed ID: 3940182 [Abstract] [Full Text] [Related]
4. Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Verma AK, Pong RC, Erickson D. Cancer Res; 1986 Dec; 46(12 Pt 1):6149-55. PubMed ID: 3779635 [Abstract] [Full Text] [Related]
5. Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation. Yamamoto S, Kiyoto I, Aizu E, Nakadate T, Hosoda Y, Kato R. Carcinogenesis; 1989 Jul; 10(7):1315-22. PubMed ID: 2544313 [Abstract] [Full Text] [Related]
6. Inhibition of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin ornithine decarboxylase and protein kinase C by polyphenolics from grapes. Bomser J, Singletary K, Meline B. Chem Biol Interact; 2000 Jun 15; 127(1):45-59. PubMed ID: 10903418 [Abstract] [Full Text] [Related]
7. Staurosporine, a potent protein kinase C inhibitor, augments phorbol ester-caused ornithine decarboxylase induction in mouse epidermis. Jiang H, Yamamoto S, Kato R. Carcinogenesis; 1992 Mar 15; 13(3):355-9. PubMed ID: 1547524 [Abstract] [Full Text] [Related]
10. Correlation of phorbol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C. Fischer SM, Jasheway DW, Klann RC, Butler AP, Patrick KE, Baldwin JK, Cameron GS. Cancer Res; 1989 Dec 01; 49(23):6693-9. PubMed ID: 2819717 [Abstract] [Full Text] [Related]
11. Characterization of the hydroperoxide response observed in mouse skin treated with tumor promoters in vivo. Perchellet EM, Perchellet JP. Cancer Res; 1989 Nov 15; 49(22):6193-201. PubMed ID: 2509065 [Abstract] [Full Text] [Related]
12. Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Weekes RG, Verma AK, Boutwell RK. Cancer Res; 1980 Nov 15; 40(11):4013-8. PubMed ID: 7471050 [Abstract] [Full Text] [Related]
13. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor. Nakadate T, Yamamoto S, Ishii M, Kato R. Cancer Res; 1982 Jul 15; 42(7):2841-5. PubMed ID: 6805948 [Abstract] [Full Text] [Related]